Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cold chain in a hot climate

S L Guthridge1, N C Miller

  • 1Territory Health Services, Darwin.

Australian and New Zealand Journal of Public Health
|December 1, 1996
PubMed
Summary
This summary is machine-generated.

Vaccine transport in the Northern Territory experienced frequent temperature deviations, with freezing posing the greatest risk to vaccine potency. Recommendations include using cold chain indicators and maintaining temperatures between 4-8°C.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Living with a Bullet in Her Brain.

The Dental register·2021
Same author

Vancomycin intermediate-resistant Staphylococcus aureus (VISA).

Orthopedic nursing·2002
Same author

Universal hepatitis B vaccination: hospital factors influencing first-dose uptake for neonates in Darwin.

Australian and New Zealand journal of public health·1998
Same author

The role of inertial particle collectors in evaluating pharmaceutical aerosol delivery systems.

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·1997
Same author

Effect of drug load and plate coating on the particle size distribution of a commercial albuterol metered dose inhaler (MDI) determined using the Andersen and Marple-Miller cascade impactors.

Pharmaceutical research·1997
Same author

A cascade impactor entry port for MDI sprays with collection characteristics imitating a physical model of the human throat.

Pharmaceutical research·1996
Same journal

The costs of diagnosing and treating skin cancer: Findings from the QSkin Study.

Australian and New Zealand journal of public health·2026
Same journal

Australians' experiences with vaping after the implementation of vape reforms: A qualitative study.

Australian and New Zealand journal of public health·2026
Same journal

What's in the Box? Analysis of the nutritional content and adoption of Health Star Ratings among packaged lunchbox snacks released in Australia: 2013-2024.

Australian and New Zealand journal of public health·2026
Same journal

Public Health at Risk: Insights from the 2026 Communicable Disease and Immunisation Conference.

Australian and New Zealand journal of public health·2026
Same journal

The potential for adverse events or harms are not routinely assessed or reported in evaluations of public health interventions.

Australian and New Zealand journal of public health·2026
Same journal

Social connection: The new frontier for better health in 2026.

Australian and New Zealand journal of public health·2026
See all related articles

Area of Science:

  • Public Health
  • Logistics
  • Immunology

Background:

  • Maintaining vaccine potency requires strict temperature control during transport and storage.
  • The Northern Territory's hot climate presents unique challenges for vaccine cold chain management.

Purpose of the Study:

  • To monitor vaccine temperatures during distribution from a national warehouse to Northern Territory clinics.
  • To identify temperature deviations and assess risks to vaccine potency.

Main Methods:

  • Electronic temperature monitors recorded temperatures every 30 minutes for up to three months.
  • Vaccine batch diaries documented location changes.
  • Over 8369 hours of temperature data were collected.

Main Results:

Related Experiment Videos

  • Regular temperature deviations outside the recommended range were observed.
  • Freezing temperatures were identified as the primary threat to vaccine potency in this region.
  • The study highlighted the vulnerability of vaccines during transit.

Conclusions:

  • Routine use of cold chain indicators is recommended.
  • Increased vaccine turnover and storage within the 4-8°C range are advised.
  • Further research into heat-stable vaccines for ambient or air-conditioned storage is warranted.